Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 1/2
This pilot study was done to see if it’s possible to do a large trial looking at quizartinib, plerixafor and ganetespib with chemotherapy for people over 60.
Recruitment start: 1 June 2011
Recruitment end: 26 April 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Alan Burnett
Bloodwise
Cardiff University
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 5 July 2018
CRUK internal database number: 7611